NCT06083571View on ClinicalTrials.gov

Intranasal Ketorolac Trial

PHASE2RecruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

January 1, 2026

Conditions

Headache, Migraine

Interventions

DRUG

Ketorolac

Non-inferiority

DRUG

Prochlorperazine

Adjunct

DRUG

Diphenhydramine

Adjunct

Trial Locations (1)

63110

RECRUITING

Washington University in St. Louis, St Louis

All Listed Sponsors

collaborator

Assertio Holdings, Inc

UNKNOWN

lead

Washington University School of Medicine

OTHER